Pyroptosis targeting via mitochondria: An educated guess to innovate COVID-19 therapies. (2022)
Attributed to:
Focusing on the mitochondrial expression of TSPO as a marker and promoter of neuroinflammation
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bph.15670
PubMed Identifier: 34632567
Publication URI: http://europepmc.org/abstract/MED/34632567
Type: Journal Article/Review
Volume: 179
Parent Publication: British journal of pharmacology
Issue: 10
ISSN: 0007-1188